US Bancorp’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.03M Sell
9,991
-7,607
-43% -$495K ﹤0.01% 1182
2026
Q1
$836K Sell
17,598
-3,768
-18% -$169K ﹤0.01% 1233
2025
Q4
$678K Buy
21,366
+20,594
+2,668% +$643K ﹤0.01% 1371
2025
Q3
$21.7K Sell
772
-232
-23% -$7.03K ﹤0.01% 3038
2025
Q2
$36.9K Sell
1,004
-169
-14% -$5.84K ﹤0.01% 2922
2025
Q1
$46K Sell
1,173
-263
-18% -$11.8K ﹤0.01% 2794
2024
Q4
$66.7K Buy
1,436
+601
+72% +$27.2K ﹤0.01% 2603
2024
Q3
$37.7K Sell
835
-163
-16% -$7.76K ﹤0.01% 2873
2024
Q2
$49.2K Buy
998
+13
+1% +$530 ﹤0.01% 2685
2024
Q1
$33.8K Sell
985
-222
-18% -$8.01K ﹤0.01% 2883
2023
Q4
$44.5K Sell
1,207
-693
-36% -$16K ﹤0.01% 2725
2023
Q3
$38.5K Sell
1,900
-150
-7% -$3.3K ﹤0.01% 2570
2023
Q2
$41.9K Buy
2,050
+1,476
+257% +$22.1K ﹤0.01% 2595
2023
Q1
$8.66K Sell
574
-315
-35% -$6.96K ﹤0.01% 3339
2022
Q4
$21.2K Sell
889
-5,679
-86% -$165K ﹤0.01% 2967
2022
Q3
$232K Buy
6,568
+4,883
+290% +$207K ﹤0.01% 1778
2022
Q2
$59K Sell
1,685
-4,257
-72% -$151K ﹤0.01% 2492
2022
Q1
$295K Buy
5,942
+626
+12% +$34.7K ﹤0.01% 1779
2021
Q4
$411K Buy
5,316
+748
+16% +$76.8K ﹤0.01% 1625
2021
Q3
$489K Buy
4,568
+10
+0.2% +$1.15K ﹤0.01% 1527
2021
Q2
$608K Buy
4,558
+493
+12% +$57.3K ﹤0.01% 1445
2021
Q1
$503K Buy
4,065
+3,996
+5,791% +$607K ﹤0.01% 1484
2020
Q4
$9K Buy
69
+28
+68% +$3.11K ﹤0.01% 3237
2020
Q3
$3K Buy
41
+16
+64% +$996 ﹤0.01% 3445
2020
Q2
$1K Buy
+25
New +$897 ﹤0.01% 3650

Other funds holding TWST

US Bancorp's TWST Position: Q2 2026 in Review

US Bancorp reduced its Twist Bioscience (TWST) stake by 43% in Q2 2026, selling an estimated $495K and leaving 9,991 shares worth $1.03M. The position accounts for ﹤0.01% of the portfolio, ranked #1182.

US Bancorp first reported a position in TWST in Q2 2020 and has held it in 25 quarters since. 336 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • US Bancorp held 9,991 shares of Twist Bioscience worth $1.03M as of Q2 2026.
  • US Bancorp sold 7,607 Twist Bioscience shares in Q2 2026, an estimated $495K.
  • Twist Bioscience made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #1182 holding.
  • US Bancorp first reported a position in Twist Bioscience in Q2 2020 and has held it in 25 quarters since.
  • 336 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.